Cargando…
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456215/ https://www.ncbi.nlm.nih.gov/pubmed/34319011 http://dx.doi.org/10.1002/advs.202100275 |
_version_ | 1784570829076430848 |
---|---|
author | Demir, Sevgican Nawroth, Peter P. Herzig, Stephan Ekim Üstünel, Bilgen |
author_facet | Demir, Sevgican Nawroth, Peter P. Herzig, Stephan Ekim Üstünel, Bilgen |
author_sort | Demir, Sevgican |
collection | PubMed |
description | Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications. |
format | Online Article Text |
id | pubmed-8456215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84562152021-09-27 Emerging Targets in Type 2 Diabetes and Diabetic Complications Demir, Sevgican Nawroth, Peter P. Herzig, Stephan Ekim Üstünel, Bilgen Adv Sci (Weinh) Reviews Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications. John Wiley and Sons Inc. 2021-07-28 /pmc/articles/PMC8456215/ /pubmed/34319011 http://dx.doi.org/10.1002/advs.202100275 Text en © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Demir, Sevgican Nawroth, Peter P. Herzig, Stephan Ekim Üstünel, Bilgen Emerging Targets in Type 2 Diabetes and Diabetic Complications |
title | Emerging Targets in Type 2 Diabetes and Diabetic Complications |
title_full | Emerging Targets in Type 2 Diabetes and Diabetic Complications |
title_fullStr | Emerging Targets in Type 2 Diabetes and Diabetic Complications |
title_full_unstemmed | Emerging Targets in Type 2 Diabetes and Diabetic Complications |
title_short | Emerging Targets in Type 2 Diabetes and Diabetic Complications |
title_sort | emerging targets in type 2 diabetes and diabetic complications |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456215/ https://www.ncbi.nlm.nih.gov/pubmed/34319011 http://dx.doi.org/10.1002/advs.202100275 |
work_keys_str_mv | AT demirsevgican emergingtargetsintype2diabetesanddiabeticcomplications AT nawrothpeterp emergingtargetsintype2diabetesanddiabeticcomplications AT herzigstephan emergingtargetsintype2diabetesanddiabeticcomplications AT ekimustunelbilgen emergingtargetsintype2diabetesanddiabeticcomplications |